Measurement of AMH has become routine in assisted reproduction as a predictor of the ovarian response to stimulation, but its potential role in diagnosing—or indeed predicting—menopause in healthy women and premature ovarian insufficiency (POI) in patients diagnosed and treated for cancer have also been recognized. This evidence concerns the gene AMH and cancer.